Deucravacitinib in plaque psoriasis: 2-year laboratory results from the phase 3 POETYK PSO program. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s119, 2023. DOI: 10.25251/skin.7.supp.119. Disponível em: https://skin.dermsquared.com/skin/article/view/1981. Acesso em: 18 apr. 2025.